EU agency OKs study of therapy to improve mitochondrial function
With a trial OK from EU regulators, Mitochon will test MP101 for improving mitochondrial function in MS and other neurodegenerative diseases.
0 Comments
EU agency OKs study of therapy to improve mitochondrial function
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed